FGFR4 and hepatocellular carcinoma: Current additional relevant targets for HCC progression prevention consist of the TGF-beta signaling pathway, fibroblast growth factor receptor 4 (FGFR4) and its associated growth factors, and colony-stimulating factor 1 (CSF-1).